Lloyd D. Fisher, Ph.D.
Biographical Sketch
Lloyd Fisher is Professor Emeritus and past Professor, Associate Chair and Director of the Graduate Program in the Department of Biostatistics at the University of Washington.
Dr. Fisher was educated at MIT (B.S. in physics), Stanford and Dartmouth (M.A. and Ph.D. in mathematics).
The author and co-author of over 340 articles and book chapters, and three books, Professor Fisher served as a new drug application, NDA, reviewer (on an expert appointment to the FDA) for about 10 years and served two four year terms as the biostatistician on the FDA Cardiovascular and Renal Drugs Advisory Committee; he has consulted and continues to consult with numerous pharmaceutical, biologic and device companies. He directed Coordinating Centers for two large NIH multicenter clinical trials: the Coronary Artery Surgery Study and the Cardiac Arrhythmia Pilot Study. He directed clinical statistics at the Fred Hutchinson Cancer Research Center for five years. He served on the Boards of Directors of the Society for Clinical Trials and the American Statistical Association; he is a fellow of the American Statistical Association, the Institute of Mathematical Statistics, the American College of Epidemiology, and the American College of Cardiology.
Dr. Fisher has served on numerous DSMBs, Data and Safey Monitoring Boards, (e.g. ACCOMPLISH, ADVANCE MI, ARISE, CART-2, CAPS, CASS, DMP 754-302, Early Acute Coronary Syndrome, Esperion ETC-588, GUSTO II, INDT [CV131-048], LOWTEMP, Organon [3 Trials], PARAGON-B, PURSUIT, RENALL, RIT-II-02, SHOCK-2, SIMPADICO, TACTICS, Takeda [3 Trials], WIZARD). He served on the BRAVO, TEMPEST and REVIVE Steering committees. He was one of a team awarded the Kappa Delta Award for Outstanding Orthopaedic Research and the Volvo award for research.
His research interests are primarily on Randomized Controlled Clinical Trials (RCTs) in particular real time monitoring issues.
For More Information
- Updated: June 7, 2005
